CNE Credit Designation Statement

Joint AccreditationIn support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing contact hours: 6.00, which includes 3.00 hours of pharmacology credit

AAPA Credit Designation Statement

AAPAContinuing Education Alliance has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.00 AAPA Category 1 CME credits. Approval is valid until March 31, 2020. PAs should only claim credit commensurate with the extent of their participation.

This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

PA Planner: Larry Herman, MPA, PA-C, University of Texas Medical Branch, Galveston

IPCE Credit Designation

IPCEThis activity was planned by and for the healthcare team, and learners will receive 6.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck.

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, or any educational supporter.

All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Thase: advisory board/consultant/grant support: Acadia, Alkermes, Allergan, Johnson & Johnson; advisory board/consultant: Cerecor, Fabre-Kramer, Gerson Lehrman Group, Guidepoint Global, H. Lundbeck, Moksha8, Nestlé, Neuralstrim, Novartis, Otsuka, Pfizer, Sage, Sunovion; grant support: Agency for Healthcare Research and Quality, AssureRx Health, Avanir, Axome, Intracellular, Janssen, National Institutes of Health/National Institute of Mental Health, Otsuka, Patient-Centered Outcomes Research Institute, Takeda; royalties: American Psychiatric Foundation, Guilford Publications, Herald House, WW Norton & Company, Inc.; spouse’s employment: Peloton Advantage.

Dr Vanacore: no relevant financial relationships to disclose.

The Planning Committee for this activity included Larry Herman, MPA, PA-C, of the University of Texas Medical Branch, Galveston; and Ruth Cohen and Leslie Burgess of Continuing Education Alliance. The members of the Planning Committee have no relevant relationships to disclose.

Participants wishing to earn CE/CME credit must:

  1. Review 4 patient charts
  2. Complete questionnaire for each patient
  3. Read 4 educational updates on MDD
  4. Complete Action Plan
  5. Review charts of 4 new patients
  6. Complete questionnaire for each new patient
  7. Complete the evaluation form after all patient information has been entered

Release date: March 31, 2019
Expiration date: March 31, 2020

For Practicing Clinicians Exchange general information, contact